Sign up Australia
Proactive Investors - Run By Investors For Investors

Creso Pharma to generate new revenue stream through cannabis beverage market

The CLV joint venture will immediately start developing a premium four-beer range.
Picture of glasses of beer
CLV's JV follows Constellation Brands' US$200 million investment in cannabis drinks

Creso Pharma Ltd (ASX:CPH) has launched its new joint venture company with LGC Capital Ltd (TSXV:LG) and Baltic Beer Company Ltd, effectively providing the vertically integrated cannabis group with a new revenue stream.

This is aimed at capitalising on the fast-growing cannabis and hemp-derived beverage markets.

The joint venture company, CLV Frontier Brands, intends to develop and globally commercialise a portfolio of cannabis and hemp-derived alcoholic and non-alcoholic beverages.

CLV will establish a pilot brewery facility in Tallinn, Estonia which will develop innovative recipes, proprietary knowledge and IP which will be registered by the group.

Creso Pharma to contribute €150,000 start-up capital

Under the terms of the joint venture agreement between Creso Pharma and LGC Capital the two companies will initially contribute €150,000 in start-up capital to CLV.

Baltic Beer Company will contribute the equivalent sum by way of services.

It is proposed that CLV will immediately start developing an initial premium four-beer range containing unique cannabis terpene mixes as well as other innovative ingredients.

Maiden commercial sales planned for third quarter of 2018

CLV expects to ship the first test batch of four different beers in April/May 2018, with commercial sales forecast to commence in the following quarter.

Potential distribution partners have been identified in Europe, East Asia, Central and Latin America, Canada, Africa, Australia and New Zealand.

CLV also plans to expand its portfolio into other alcoholic and non-alcoholic beverages, seemingly at an opportune time judging by market activity.

Industry undergoing strong growth

In October 2017, global beverage conglomerate Constellation Brands (NYSE:STZ) took a 9.9 per cent stake in cannabis group, Canopy Growth, for a total of US$200 million with a view to developing and marketing cannabis-infused drinks.

Data released by globenewswire.com indicates that the global craft beer market will deliver compound annual growth of circa 11% between 2017 and 2021.

View full CPH profile View Profile

Creso Pharma Ltd Timeline

Newswire
March 20 2017

Related Articles

Graphic of person pointing to different parts of the body
May 14 2018
Paradigm’s share price has increased more than 60% in the last month and it was up more than 12% on Friday.
Laboratory
June 21 2018
Genedrive has signed sales agreement with Sysmex Corporation for the distribution of the HCV ID to EMEA and Asia Pacific and with Mumbai- based ARKRAY to distribute the kit in India
1524140870_ampoules.jpg
April 19 2018
US food and drug administration approval isn't there yet, but Motif continues to chug forwards

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use